OBJECTIVE: We propose new statistical methods for analyzing genetic case/control association data in which cases can be further classified into subtypes, for example, based on clinical features. The primary utility of our work is the ability to distinguish between subtype-specific and modifier effects of genetic variants within a single testing framework. METHODS: A range of disease/subtype causal models are defined for genetic variants involving subtype-specific and modifier effects. We present a log-linear modeling framework enabling comparison between these causal models and selection of the best-fit model. RESULTS: We evaluate and compare the analytic power and model selection performance of the proposed work with standard two-group-based association tests. Simulation studies demonstrate that our approach has similar or greater power than the traditional approach over a range of causal models. We also report empirical findings about the impact of misspecification of subtype frequency during model selection, and extend the application of the proposed work to the cross-disorder association studies of multiple diseases. CONCLUSION: Whether a variant is a disease risk factor, is subtype specific, or modifies disease features has important consequences for the interpretation and follow-up of genetic associations. Our framework provides a simple, systematic way to evaluate and describe associations involving such subtype-specific or modifier effects.
OBJECTIVE: We propose new statistical methods for analyzing genetic case/control association data in which cases can be further classified into subtypes, for example, based on clinical features. The primary utility of our work is the ability to distinguish between subtype-specific and modifier effects of genetic variants within a single testing framework. METHODS: A range of disease/subtype causal models are defined for genetic variants involving subtype-specific and modifier effects. We present a log-linear modeling framework enabling comparison between these causal models and selection of the best-fit model. RESULTS: We evaluate and compare the analytic power and model selection performance of the proposed work with standard two-group-based association tests. Simulation studies demonstrate that our approach has similar or greater power than the traditional approach over a range of causal models. We also report empirical findings about the impact of misspecification of subtype frequency during model selection, and extend the application of the proposed work to the cross-disorder association studies of multiple diseases. CONCLUSION: Whether a variant is a disease risk factor, is subtype specific, or modifies disease features has important consequences for the interpretation and follow-up of genetic associations. Our framework provides a simple, systematic way to evaluate and describe associations involving such subtype-specific or modifier effects.
Authors: Jie Huang; Roy H Perlis; Phil H Lee; A John Rush; Maurizio Fava; Gary S Sachs; Jeffrey Lieberman; Steven P Hamilton; Patrick Sullivan; Pamela Sklar; Shaun Purcell; Jordan W Smoller Journal: Am J Psychiatry Date: 2010-08-16 Impact factor: 18.112
Authors: P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close Journal: Mol Psychiatry Date: 2008-03-18 Impact factor: 15.992
Authors: Nick Craddock; Kenneth Kendler; Michael Neale; John Nurnberger; Shaun Purcell; Marcella Rietschel; Roy Perlis; Susan L Santangelo; Thomas G Schulze; Thomas Schulze; Jordan W Smoller; Anita Thapar Journal: Br J Psychiatry Date: 2009-08 Impact factor: 9.319
Authors: Paul Lichtenstein; Benjamin H Yip; Camilla Björk; Yudi Pawitan; Tyrone D Cannon; Patrick F Sullivan; Christina M Hultman Journal: Lancet Date: 2009-01-17 Impact factor: 79.321
Authors: Samsiddhi Bhattacharjee; Preetha Rajaraman; Kevin B Jacobs; William A Wheeler; Beatrice S Melin; Patricia Hartge; Meredith Yeager; Charles C Chung; Stephen J Chanock; Nilanjan Chatterjee Journal: Am J Hum Genet Date: 2012-05-04 Impact factor: 11.025
Authors: Jenna C Carlson; Jennifer Standley; Aline Petrin; John R Shaffer; Azeez Butali; Carmen J Buxó; Eduardo Castilla; Kaare Christensen; Frederic W-D Deleyiannis; Jacqueline T Hecht; L Leigh Field; Ariuntuul Garidkhuu; Lina M Moreno Uribe; Natsume Nagato; Ieda M Orioli; Carmencita Padilla; Fernando Poletta; Satoshi Suzuki; Alexandre R Vieira; George L Wehby; Seth M Weinberg; Terri H Beaty; Eleanor Feingold; Jeffrey C Murray; Mary L Marazita; Elizabeth J Leslie Journal: Genet Epidemiol Date: 2017-11-10 Impact factor: 2.135
Authors: Jie Huang; Roy H Perlis; Phil H Lee; A John Rush; Maurizio Fava; Gary S Sachs; Jeffrey Lieberman; Steven P Hamilton; Patrick Sullivan; Pamela Sklar; Shaun Purcell; Jordan W Smoller Journal: Am J Psychiatry Date: 2010-08-16 Impact factor: 18.112
Authors: Tim B Bigdeli; Stephan Ripke; Silviu-Alin Bacanu; Sang Hong Lee; Naomi R Wray; Pablo V Gejman; Marcella Rietschel; Sven Cichon; David St Clair; Aiden Corvin; George Kirov; Andrew McQuillin; Hugh Gurling; Dan Rujescu; Ole A Andreassen; Thomas Werge; Douglas H R Blackwood; Carlos N Pato; Michele T Pato; Anil K Malhotra; Michael C O'Donovan; Kenneth S Kendler; Ayman H Fanous Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-12-11 Impact factor: 3.568
Authors: Daniel I Chasman; Verneri Anttila; Julie E Buring; Paul M Ridker; Markus Schürks; Tobias Kurth Journal: PLoS Genet Date: 2014-05-22 Impact factor: 5.917